TLR2 inhibition reprograms the tumor microenvironment and delays progression of recurrent ovarian cancer in vivo

被引：0
|
作者：
Alvero, A. [1 ]
Pitruzzello, M. [1 ]
Keogh, B. [2 ]
Mcguirk, P. [2 ]
Reilly, M. [2 ]
Mor, G. [1 ]
机构：
[1] Yale Univ, Ob Gyn, New Haven, CT USA
[2] Opsona Therapeut Ltd, Vivo Pharmacol, Dublin, Ireland
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
320 (PB-08
引用
收藏
页码：E107 / E107
页数：1
相关论文
共 50 条
  • [21] Combined MEK and STAT3 inhibition reprograms the tumor microenvironment to overcome immunotherapy resistance in pancreatic cancer
    Garrido, Vanessa Tonin
    Datta, Jashodeep
    Dai, Xizi
    Bianchi, Anna
    Silva, Iago De Castro
    Lamichhane, Purushottam
    Mehra, Siddharth
    Singh, Samara P.
    Dosch, Austin R.
    Umland, Oliver
    VanSaun, Michael N. N.
    Hosein, Peter J.
    Nagathihalli, Nagaraj
    Merchant, Nipun
    CANCER RESEARCH, 2022, 82 (12)
  • [22] TLR2 and TLR4 in colorectal cancer: relationship to tumor necrosis and markers of systemic inflammation
    Paarnio, Karoliina
    Vaeyrynen, Juha P.
    Vaeyrynen, Sara A.
    Kantola, Tiina
    Karhu, Timo
    Tervahartiala, Taina
    Klintrup, Kai
    Sorsa, Timo
    Salo, Tuula
    Maekelae, Jyrki
    Karttunen, Tuomo J.
    NEOPLASMA, 2022, 69 (06) : 1418 - +
  • [23] Changes in the tumor immune microenvironment during disease progression in clear cell ovarian cancer
    Woo, Ha Young
    Kim, Na Yeon
    Jun, Jinok
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sung-Hoon
    Kim, Young-Tae
    Lee, Yong Jae
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [24] INHIBITION OF TUMOR MICROENVIRONMENT CYTOKINE SIGNALING SENSITIZES OVARIAN CANCER CELLS TO ANTIESTROGEN THERAPY
    Tan, Lijun
    Prince, Victoria
    Erba, Jake
    McLean, Karen
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 166 - 166
  • [25] Therapeutic AXL inhibition of tumor and tumor microenvironment stromal cells improves response to chemotherapy in ovarian cancer
    Mullen, M. M.
    Lomonosova, E.
    Beck-Noia, H.
    Wilke, D.
    Guo, L.
    Hagemann, A. R.
    Kuroki, L. M.
    McCourt, C. K.
    Thaker, P. H.
    Mutch, D. G.
    Powell, M. A.
    Fuh, K. C.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 35 - 35
  • [26] Inhibition of Tumor Microenvironment Cytokine Signaling Sensitizes Ovarian Cancer Cells to Antiestrogen Therapy
    Tan, Lijun
    Tondo-Steele, Katelyn
    Foster, Caroline
    McIlwain, Carrie
    Bolland, Danielle E.
    Crawford, Howard C.
    Sciallis, Andrew
    McLean, Karen
    CANCERS, 2022, 14 (19)
  • [27] Tumor microenvironment of colorectal cancer: toll like receptor 4 (TLR4) as a marker of progression
    Albini, Adriana
    Cammarota, Rosaria
    Bertolini, Valentina
    Pennesi, Giuseppina
    Bucci, Eraldo Oreste
    Garlanda, Cecilia
    Laghi, Luigi
    Barberis, Massimo Costanzo
    Sessa, Fausto
    Noonan, Douglas McCain
    CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (02) : 172 - 172
  • [28] Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer
    Myung, Jae-Kyung
    Wang, Gang
    Chiu, Helen H. L.
    Wang, Jun
    Mawji, Nasrin R.
    Sadar, Marianne D.
    PLOS ONE, 2017, 12 (03):
  • [29] Excessive HSP70/TLR2 activation leads to remodeling of the tumor immune microenvironment to resist chemotherapy sensitivity of mFOLFOX in colorectal cancer
    Feng, Haoran
    Guo, Zichao
    Chen, Xianze
    Liu, Kun
    Li, Haosheng
    Jia, Wenqing
    Wang, Changgang
    Luo, Fangxiu
    Ji, Xiaopin
    Zhang, Tao
    Zhao, Ren
    Cheng, Xi
    CLINICAL IMMUNOLOGY, 2022, 245
  • [30] Inhibition of Ovarian Cancer Growth, Metastasis and Reverse the Tumor Microenvironment by Dual Drug-Loaded Polymer Micelle Targeting Tumor Microenvironment
    Zhang, Lu
    Guo, Ruibo
    Chen, Muhan
    Liu, Mo
    Liu, Yang
    Yu, Yang
    Zang, Juan
    Kong, Liang
    Li, Xuetao
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2025, 20 : 2969 - 2990
12345